ALICJA WEYRICH: Open Payments
NPI 1063157048 · BATAVIA, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,187 in 33 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $455 · 2025 $1,187
Food & beverage: $1,087Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $314 |
| UCB, Inc. | 4 | $194 |
| Arcutis Biotherapeutics, Inc. | 1 | $165 |
| Incyte Corporation | 4 | $156 |
| Galderma Laboratories, L.P. | 8 | $146 |
| ABBVIE INC. | 3 | $72 |
| Regeneron Healthcare Solutions, Inc. | 2 | $47 |
| GENZYME CORPORATION | 1 | $34 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $21 |
| Organon LLC | 2 | $19 |
Products named: TREMFYA, Bimzelx, Zoryve, OPZELURA, DUPIXENT, AKLIEF, RINVOQ, NEMLUVIO.
Industry payments across IL — which companies pay providers there.
